S. Tanaka, D. N. Louis, W. T. Curry, T. T. Batchelor, and J. Dietrich, Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?, Nature Reviews Clinical Oncology, vol.455, issue.1, pp.14-26, 2012.
DOI : 10.1038/nrclinonc.2012.204

T. F. Cloughesy, W. K. Cavenee, P. S. Mischel, and . Glioblastoma, From molecular pathology to targeted treatment, Annu. Rev. Pathol, pp.10-1146, 2013.

L. Yang, C. Lin, L. Wang, H. Guo, and X. Wang, Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications, Experimental Cell Research, vol.318, issue.19, pp.318-2417, 2012.
DOI : 10.1016/j.yexcr.2012.07.017

B. L. Krock, N. Skuli, and M. C. Simon, Hypoxia-Induced Angiogenesis: Good and Evil, Genes & Cancer, vol.2, issue.12, pp.1117-1133, 2011.
DOI : 10.1177/1947601911423654

B. Keith, R. S. Johnson, and M. C. Simon, HIF1?? and HIF2??: sibling rivalry in hypoxic tumour growth and progression, Nature Reviews Cancer, vol.1, pp.9-22, 2012.
DOI : 10.1038/nrc3183

L. Chen, A. Endler, and F. Shibasaki, Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors, Experimental and Molecular Medicine, vol.98, issue.12, pp.849-857, 2009.
DOI : 10.3858/emm.2009.41.12.103

A. Pietras, A. S. Johnsson, and S. Pahlman, The HIF-2??-Driven Pseudo-Hypoxic Phenotype in Tumor Aggressiveness, Differentiation, and Vascularization, Curr. Top. Microbiol. Immunol, vol.345, pp.1-20, 2010.
DOI : 10.1007/82_2010_72

Z. Li, S. Bao, Q. Wu, H. Wang, C. Eyler et al., Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells, Cancer Cell, vol.15, issue.6, pp.501-513, 2009.
DOI : 10.1016/j.ccr.2009.03.018

L. Chen, K. Uchida, A. Endler, and F. Shibasaki, Mammalian Tumor Suppressor Int6 Specifically Targets Hypoxia Inducible Factor 2?? for Degradation by Hypoxia- and pVHL-independent Regulation, Journal of Biological Chemistry, vol.282, issue.17, pp.12707-12716, 2007.
DOI : 10.1074/jbc.M700423200

R. Miyashita, L. Chen, H. Oshiro, H. Uchino, and F. Shibasaki, Int6 silencing causes induction of angiogenic factors in neuronal cells via accumulation of hypoxia-inducible factor 2?? and decreases brain damage in rats, Neuroscience Letters, vol.528, issue.1, pp.83-88, 2006.
DOI : 10.1016/j.neulet.2012.08.033

L. Chen, A. Endler, K. Uchida, S. Horiguchi, Y. Morizane et al., Int6/eIF3e Silencing Promotes Functional Blood Vessel Outgrowth and Enhances Wound Healing by Upregulating Hypoxia-Induced Factor 2?? Expression, Circulation, vol.122, issue.9, pp.910-919, 2010.
DOI : 10.1161/CIRCULATIONAHA.109.931931

A. Endler, L. Chen, Q. Li, K. Uchida, T. Hashimoto et al., Int6/eIF3e silenced HIF2?? stabilization enhances migration and tube formation of HUVECs via IL-6 and IL-8 signaling, Cytokine, vol.62, issue.1, pp.115-122, 2013.
DOI : 10.1016/j.cyto.2013.01.021

D. Silvera, S. C. Formenti, and R. J. Schneider, Translational control in cancer, Nature Reviews Cancer, vol.5, issue.4, pp.254-266, 2010.
DOI : 10.1038/nrc2824

J. W. Hershey, Regulation of protein synthesis and the role of eIF3 in cancer, Brazilian Journal of Medical and Biological Research, vol.43, issue.10, pp.920-930, 2010.
DOI : 10.1590/S0100-879X2010007500098

E. Damoc, C. S. Fraser, M. Zhou, H. Videler, G. L. Mayeur et al., Structural Characterization of the Human Eukaryotic Initiation Factor 3 Protein Complex by Mass Spectrometry, Molecular & Cellular Proteomics, vol.6, issue.7, pp.1135-1146, 2007.
DOI : 10.1074/mcp.M600399-MCP200

R. Marchione, S. A. Leibovitch, and J. L. Lenormand, The translational factor eIF3f: the ambivalent eIF3 subunit, Cellular and Molecular Life Sciences, vol.276, issue.1 Pt 1, pp.3603-3616, 2013.
DOI : 10.1007/s00018-013-1263-y

URL : https://hal.archives-ouvertes.fr/hal-00821154

C. Morris, N. Tomimatsu, D. J. Richard, D. Cluet, S. Burma et al., INT6/EIF3E Interacts with ATM and Is Required for Proper Execution of the DNA Damage Response in Human Cells, Cancer Research, vol.72, issue.8, pp.2006-2016, 2012.
DOI : 10.1158/0008-5472.CAN-11-2562

URL : https://hal.archives-ouvertes.fr/ensl-00807724

M. Grzmil, T. Rzymski, M. Milani, A. L. Harris, R. G. Capper et al., An oncogenic role of eIF3e/INT6 in human breast cancer, Oncogene, vol.86, issue.28, pp.4080-4089, 2010.
DOI : 10.1186/1741-7007-3-14

L. D. Gillis and S. M. Lewis, Decreased eIF3e/Int6 expression causes epithelial-to-mesenchymal transition in breast epithelial cells, Oncogene, vol.16, issue.31, pp.3598-3605, 2012.
DOI : 10.1038/onc.2012.371

F. Cappuzzo, M. Varella-garcia, E. Rossi, S. Gajapathy, M. Valente et al., MYC and EIF3H Coamplification Significantly Improve Response and Survival of Non-small Cell Lung Cancer Patients (NSCLC) Treated with Gefitinib, Journal of Thoracic Oncology, vol.4, issue.4, pp.472-478, 2009.
DOI : 10.1097/JTO.0b013e31819a5767

T. Visakorpi, Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer, Am. J. Pathol, vol.154, pp.1777-1783, 1999.

D. R. Scoles, W. H. Yong, Y. Qin, K. Wawrowsky, and S. M. Pulst, Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c), Human Molecular Genetics, vol.15, issue.7
DOI : 10.1093/hmg/ddl021

H. Liang, X. Ding, C. Zhou, Y. Zhang, M. Xu et al., Knockdown of eukaryotic translation initiation factors 3B (EIF3B) inhibits proliferation and promotes apoptosis in glioblastoma cells, Neurological Sciences, vol.432, issue.5, pp.1057-1062, 2012.
DOI : 10.1007/s10072-011-0894-8

S. Miyazaki, C. A. Kozak, A. Marchetti, F. Buttitta, D. Gallahan et al., The Chromosomal Location of the Mouse Mammary Tumor Gene Int6 and Related Pseudogenes in the Mouse Genome, Genomics, vol.27, issue.3, pp.420-424, 1995.
DOI : 10.1006/geno.1995.1072

S. Miyazaki, A. Imatani, L. Ballard, A. Marchetti, F. Buttitta et al., The Chromosome Location of the Human Homolog of the Mouse Mammary Tumor-Associated GeneINT6and Its Status in Human Breast Carcinomas, Genomics, vol.46, issue.1, pp.155-158, 1997.
DOI : 10.1006/geno.1997.4996

F. Buttitta, C. Martella, F. Barassi, L. Felicioni, S. Salvatore et al., Int6 Expression Can Predict Survival in Early-Stage Non-Small Cell Lung Cancer Patients, Clinical Cancer Research, vol.11, issue.9, pp.3198-3204, 2005.
DOI : 10.1158/1078-0432.CCR-04-2308

A. Umar, H. Kang, A. M. Timmermans, M. P. Look, M. E. Meijer-van-gelder et al., Identification of a Putative Protein Profile Associated with Tamoxifen Therapy Resistance in Breast Cancer, Molecular & Cellular Proteomics, vol.8, issue.6, pp.1278-1294, 2009.
DOI : 10.1074/mcp.M800493-MCP200

E. C. Chang, Int6 regulates both proteasomal degradation and translation initiation and is critical for proper formation of acini by human mammary epithelium, Oncogene, vol.30, pp.724-736, 2010.

C. Morris and P. Jalinot, Silencing of human Int-6 impairs mitosis progression and inhibits cyclin B???Cdk1 activation, Oncogene, vol.24, issue.7, pp.1203-1211, 2005.
DOI : 10.1038/sj.onc.1208268

M. Grzmil, D. Whiting, J. Maule, C. Anastasaki, J. F. Amatruda et al., The INT6 Cancer Gene and MEK Signaling Pathways Converge during Zebrafish Development, PLoS ONE, vol.15, issue.9, p.959, 2007.
DOI : 10.1371/journal.pone.0000959.s004

J. Kessler, A. Hahnel, H. Wichmann, S. Rot, M. Kappler et al., HIF-1?? inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression, BMC Cancer, vol.284, issue.1, p.605, 2010.
DOI : 10.1074/jbc.M109.009498

R. L. Jensen, B. T. Ragel, K. Whang, and D. Gillespie, Inhibition of hypoxia inducible factor-1?? (HIF-1??) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas, Journal of Neuro-Oncology, vol.65, issue.3, pp.233-247, 2006.
DOI : 10.1007/s11060-005-9103-z

D. L. Gillespie, K. Whang, B. T. Ragel, J. R. Flynn, D. A. Kelly et al., Silencing of Hypoxia Inducible Factor-1?? by RNA Interference Attenuates Human Glioma Cell Growth In vivo, Clinical Cancer Research, vol.13, issue.8, pp.2441-2448, 2007.
DOI : 10.1158/1078-0432.CCR-06-2692

A. Franovic, C. E. Holterman, J. Payette, and S. Lee, Human cancers converge at the HIF-2?? oncogenic axis, Proc. Natl. Acad. Sci, pp.21306-21311, 2009.
DOI : 10.1073/pnas.0906432106

C. Morris, J. Wittmann, H. M. Jack, and P. Jalinot, Human INT6/eIF3e is required for nonsense-mediated mRNA decay, EMBO reports, vol.3, issue.6, pp.596-602, 2007.
DOI : 10.1038/sj.embor.7400955

X. Zhang, T. Chen, J. Zhang, Q. Mao, S. Li et al., Notch1 promotes glioma cell migration and invasion by stimulating ??-catenin and NF-??B signaling via AKT activation, Cancer Science, vol.12, issue.1-3, pp.181-190, 2012.
DOI : 10.1111/j.1349-7006.2011.02154.x

W. J. Kil, P. J. Tofilon, and K. Camphausen, Post-radiation increase in VEGF enhances glioma cell motility in vitro, Radiation Oncology, vol.7, issue.1, 2012.
DOI : 10.1016/S0304-3835(02)00278-1

C. Xu, X. Wu, and J. Zhu, Vegf promotes proliferation of human glioblastoma multiforme stem-like cells through vegf receptor 2. Sci, 2013.

I. Nazarenko, S. M. Hede, X. He, A. Hedren, J. Thompson et al., Pdgf and pdgf receptors in glioma. Ups, J. Med. Sci, vol.117, pp.99-112, 2012.

T. Taga, A. Suzuki, I. Gonzalez-gomez, F. H. Gilles, M. Stins et al., ?v-Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin, International Journal of Cancer, vol.46, issue.87, pp.690-697, 2002.
DOI : 10.1002/ijc.10265

T. J. Macdonald and S. Ladisch, Antisense to integrin alpha v inhibits growth and induces apoptosis in medulloblastoma cells, Anticancer Res, vol.21, pp.3785-3791, 2001.

J. M. Heddleston, Z. Li, R. E. Mclendon, A. B. Hjelmeland, and J. N. Rich, The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype, Cell Cycle, vol.8, issue.20, pp.3274-3284, 2009.
DOI : 10.4161/cc.8.20.9701

J. M. Heddleston, Z. Li, J. D. Lathia, S. Bao, A. B. Hjelmeland et al., Hypoxia inducible factors in cancer stem cells, British Journal of Cancer, vol.106, issue.5, pp.789-795, 2010.
DOI : 10.1038/sj.bjc.6605551

N. Skuli, S. Monferran, C. Delmas, I. Lajoie-mazenc, G. Favre et al., Activation of RhoB by Hypoxia Controls Hypoxia-Inducible Factor-1?? Stabilization through Glycogen Synthase Kinase-3 in U87 Glioblastoma Cells, Cancer Research, vol.66, issue.1, pp.482-489, 2006.
DOI : 10.1158/0008-5472.CAN-05-2299

N. Skuli, A. J. Majmundar, B. L. Krock, R. C. Mesquita, L. K. Mathew et al., Endothelial HIF-2?? regulates murine pathological angiogenesis and revascularization processes, Journal of Clinical Investigation, vol.122, issue.4, pp.1427-1443, 2012.
DOI : 10.1172/JCI57322DS1